Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Baumann, Stefan [VerfasserIn]   i
 Werner, Nikos [VerfasserIn]   i
 Al-Rashid, Fadi [VerfasserIn]   i
 Schaefer, Andreas [VerfasserIn]   i
 Bauer, Timm [VerfasserIn]   i
 Sotoudeh, Ramin [VerfasserIn]   i
 Bojara, Waldemar [VerfasserIn]   i
 Shamekhi, Jasmin [VerfasserIn]   i
 Sinning, Jan-Malte [VerfasserIn]   i
 Becher, Tobias [VerfasserIn]   i
 Eder, Frederik [VerfasserIn]   i
 Akın, Ibrahim [VerfasserIn]   i
Titel:Six months follow-up of protected high-risk percutaneous coronary intervention with the microaxial Impella pump
Titelzusatz:results from the German Impella registry
Verf.angabe:Stefan Baumann, Nikos Werner, Fadi Al-Rashid, Andreas Schaefer, Timm Bauer, Ramin Sotoudeh, Waldemar Bojara, Jasmin Shamekhi, Jan-Malte Sinning, Tobias Becher, Frederik Eder, Ibrahim Akin
Jahr:2020
Umfang:6 S.
Fussnoten:Gesehen am 08.07.2020
Titel Quelle:Enthalten in: Coronary artery disease
Ort Quelle:London : Lippincott Williams & Wilkins, 1990
Jahr Quelle:2020
Band/Heft Quelle:31(2020), 3, Seite 237-242
ISSN Quelle:1473-5830
Abstract:Background: Percutaneous coronary intervention (PCI) represents an important alternative to coronary bypass surgery for the treatment of patients with complex coronary artery disease and high perioperative risk. Protected percutaneous coronary intervention applies temporary percutaneous ventricular assist devices to mitigate potential hemodynamic compromise in high-risk patients. The Impella system is currently the most commonly used device for protected percutaneous coronary intervention and showed improved hemodynamic parameters in earlier trials. Methods: This study was designed as a retrospective, observational multi-center registry conducted in ten hospitals in Germany. We included consecutive patients undergoing protected high-risk percutaneous coronary intervention with Impella support. The primary endpoint was defined as the occurrence of a major adverse cardiac event defined as all-cause mortality, ST-elevation myocardial infarction, or stroke during a postprocedural 180-day follow-up period. Results: In total, 157 patients (80.3% male; mean age 71.8 +/- 10.8 years) were included in the present study, and 180-day follow-up was complete for 149 patients (94.9%). At baseline, the patients had a median left ventricular ejection fraction of 39.0% (interquartile range, 25.0-50.0%). The median SYNergy between PCI with TAXUS and Cardiac Surgery-Score I was 33.0 (interquartile range, 24.0-40.5) and the median EuroSCORE II was 7.2% (interquartile range, 3.2-17.1%). During postprocedural follow-up, 34 patients (22.8%) suffered a major adverse cardiac event. All-cause mortality was 18.1% (27 patients). Nine patients (6.0%) sustained a ST-elevation myocardial infarction, while 4 patients (2.7%) had a stroke. Conclusions: Patients undergoing protected high-risk percutaneous coronary intervention with Impella support showed an acceptable 180-day clinical outcome regarding major adverse cardiac event and mortality.
DOI:doi:10.1097/MCA.0000000000000824
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.1097/MCA.0000000000000824
 DOI: https://doi.org/10.1097/MCA.0000000000000824
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:assist device
 bypass-surgery
 clinical characteristics
 guidelines
 hemodynamic support
 Impella
 intraaortic balloon pump
 outcomes
 prediction
 protected percutaneous coronary intervention
 support
 ventricular assist device
K10plus-PPN:1713926946
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68614719   QR-Code

zum Seitenanfang